Coll2-1 in viscosupplementation: results from Epikart study

Artialis' biomarker Coll2-1 and viscosupplementation of hyaluronic acid: results from EPIKART, a Pilot Prospective Comparative Randomized Double Blind Trial.

Published on 07/06/2017

Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial.




 © Artialis - All rights reserved
Terms & conditions - Privacy Policy